©
Zhi Yi Wong
Germinal centre (GC) B cells are important for establishing immune defence. Despite having some of the highest proliferation rates among mammalian cells, their metabolism remains unusual and not fully understood. A team from the Kennedy Institute and collaborators has shed light on this critical process.
The findings, published as a research article in Science Immunology, identify the non-essential amino acid asparagine as a critical regulator of germinal centre (GC) B cell function, structures critical for refining antibodies to target infections effectively.
‘When asparagine is scarce, B cells struggle, leading to weakened GC B cell function’ said Yavuz Yazicioglu, KTPS DPhil student and first author of the study.
Reducing asparagine levels through diet or an asparagine-depleting drug, Asparaginase, weakened GC B cell function, leading to lower-quality antibody generation during flu infection, particularly from the cells with a defective capacity to produce asparagine.
‘We found when B cells were deprived of asparagine, they had reduced mitochondrial activity and building blocks such as nucleotides, suggesting asparagine sustains important metabolic processes in B cells,’ said Alex Clarke, Wellcome Trust Clinical Research Career Development Fellow. Alex further commented on the significance of their findings: ‘Our work highlights asparagine metabolism as a metabolic vulnerability in B cells that can be targeted to tackle diseases such as autoimmunity or malignancies with abnormal B cell immune responses.’
The study was funded by the Wellcome Trust, Cancer Research UK, and Versus Arthritis.